What does Meningate do?
Meningate is a biotech company specializing in innovative solutions for the treatment and prevention of meningitis. It focuses on developing advanced vaccines and therapeutic approaches to address the challenges posed by bacterial and viral infections. Through its research and development efforts, Meningate aims to improve public health outcomes and enhance patient care.
- Signals
-
ProfitableProfitable € 441K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 2.11MStrong equity provides a buffer against setbacks.
Low riskLow risk 57.0%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 649KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 723KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 7.5%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2026
|
2025
|
2024
|
2023
|
|---|---|---|---|---|
|
€
953K
|
€
875K
|
€
721K
|
€
409K
|
|
|
€
723K
|
€
668K
|
€
509K
|
€
206K
|
|
|
€
441K
|
€
514K
|
€
382K
|
€
78K
|
|
|
€
2.11M
|
€
1.70M
|
€
1.89M
|
€
1.54M
|
|
|
57.01%
|
49.69%
|
62.36%
|
58.21%
|
|
|
€
1.59M
|
€
1.72M
|
€
1.14M
|
€
1.10M
|
|
|
€
331K
|
€
314K
|
€
365K
|
€
105K
|
|
|
3.20
|
3.70
|
3.80
|
4.50
|
Publications 16
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Diversen - Ontslagen - Benoemingen 05/01/2024
- Me. - Jaarrekening 31.03.2016, Ggk 03.09.2016, Ngl 26.09.2016 16614-0442-017 30/09/2016
- Me. - Jaarrekening 31.03.2015, Ggk 05.09.2015, Ngl 28.09.2015 15608-0113-017 01/10/2015
- Me. - Jaarrekening 31.03.2014, Ggk 06.09.2014, Ngl 22.09.2014 14594-0026-017 25/09/2014
- Kapitaal - Aandelen 10/01/2014
Frequently asked questions
Answers to the most common questions about Meningate, based on official government data and the filed annual accounts.
What is the VAT number of Meningate?
The VAT number of Meningate is BE0863.765.895.
How many employees work at Meningate?
In 2026, Meningate employed 3.20 full-time equivalents (FTE).
When was Meningate established?
Meningate was founded in 02-03-2004.
What is the official address of Meningate?
The official address of Meningate is Hoge Wieltjesgracht 1 Glva Ieper 8900.
What is the legal form of Meningate?
The juridical form of Meningate is Private limited company (BV/SRL).
What is the annual revenue of Meningate?
The 2026 accounts of Meningate do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Meningate do?
Meningate is a biotech company specializing in innovative solutions for the treatment and prevention of meningitis. It focuses on developing advanced vaccines and therapeutic approaches to address the challenges posed by bacterial and viral infections. Through its research and development efforts, Meningate aims to improve public health outcomes and enhance patient care.
Is Meningate a reliable company?
Meningate is a registered Rechtspersoon with company number 0863.765.895 and can be verified through the official CBE database.
What is the credit limit of Meningate?
The estimated credit limit of Meningate is €816,313.
Is Meningate still active?
Meningate currently has the status "Normal situation" and is active.